The weekly litigation news digest is live. Subscribe now

IP Verse

Modulation Of Alpha Synuclein Expression

Patent No. EP2640853 (titled "Modulation Of Alpha Synuclein Expression") was filed by Ionis Pharmaceuticals on Nov 17, 2011. The application was issued on Dec 26, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
HOFFMANN EITLESep 25, 2019HOFFMANN EITLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2640853

IONIS PHARMACEUTICALS
Application Number
EP11840796A
Filing Date
Nov 17, 2011
Status
Revoked
Oct 21, 2024
Publication Date
Dec 26, 2018
External Links
Slate, EP2640853B1, Google Patents